Skip to main content
. 2026 Feb 4;19(2):267. doi: 10.3390/ph19020267
MTX Methotrexate
MTX-PG Methotrexate polyglutamate
IMID Immune-mediated inflammatory diseases
Ped-ALL Pediatric acute lymphoblastic leukemia
RA Rheumatoid arthritis
JIA Juvenile idiopathic arthritis
CD Crohn’s diseases
FPGS Folyl-polyglutamate synthetase
TDM Therapeutic drug monitoring
SNP Single nucleotide polymorphism
S.C. Subcutaneous
I.V. Intravenous
I.Th. Intrathecal
DMARD Disease-modifying anti-rheumatic drugs
HCQ Hydroxychloroquine
SSZ Sulfasalazine
UPLC-MS/MS Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
BMI Body mass index
BSA Body surface area
eGFR Estimated glomerular filtration rate
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration
MICE Multiple imputation by chained equations
SD Standard deviation
IQR Interquartile range
AO Aldehyde oxidase
RFC Reduced folate carrier
Km Michaelis constant